Mother's Own Milk Biomarkers Predict Coming to Volume in Pump-Dependent Mothers of Preterm Infants.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
01 2021
Historique:
received: 28 02 2020
revised: 02 09 2020
accepted: 03 09 2020
pubmed: 12 9 2020
medline: 3 2 2021
entrez: 11 9 2020
Statut: ppublish

Résumé

To assess serial secretory activation biomarker concentrations (sodium [Na], potassium [K], Na:K, protein, lactose, and citrate) in mother's own milk (MOM) from breast pump-dependent mothers of preterm infants to determine associations with coming to volume (CTV), defined as producing at least 500 mL/day MOM by day 14 postpartum. We collected serial MOM samples and pumped MOM volume data for 14 days postpartum in mothers who delivered at <33 weeks of gestation. Regression models and the Mann-Whitney U test were used to evaluate associations. Among 40 mothers, 39 (mean gestational age, 28.8 weeks; 67% overweight/obese; 59% nonwhite) had paired MOM volume and biomarker data; 33% achieved CTV between postpartum days 6 and 14. In univariate models, MOM Na on postpartum day 5 and Na:K on days 3 and 5 were associated with CTV. Mothers achieving CTV were more likely to have postpartum Na:K ≤1 on day 3 (75% vs 25%; P = .06) and ≤0.8 on day 5 (69% vs 10%; P < .01). In a multivariable regression model, day 5 Na:K (1 unit decrease in Na:K: OR, 18.7; 95% CI, 1.13-311.41; P = .049) and maternal prepregnancy body mass index (BMI) (1 unit increase in BMI: OR, 0.88; 95% CI, 0.78-0.99; P = .04) were associated with CTV between postpartum days 6 and 14. Secretory activation and CTV were compromised in breast pump-dependent mothers with preterm delivery. CTV was predicted by MOM Na level and Na:K. These biomarkers have potential as objective point-of-care measures to detect potentially modifiable lactation problems in a high-risk population.

Identifiants

pubmed: 32916143
pii: S0022-3476(20)31138-0
doi: 10.1016/j.jpeds.2020.09.010
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-52.e3

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Rebecca Hoban (R)

Division of Neonatology, Department of Pediatrics, Rush University Medical Center, Chicago, IL; Division of Neonatology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. Electronic address: rebecca.hoban@sickkids.ca.

Clarisa Medina Poeliniz (C)

College of Nursing, Rush University Medical Center, Chicago, IL.

Emily Somerset (E)

Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.

Ching Tat Lai (C)

School of Molecular Sciences, University of Western Australia, Perth, WA, Australia.

Judy Janes (J)

Department of Women and Children's Nursing, Rush University Medical Center, Chicago, IL.

Aloka L Patel (AL)

Division of Neonatology, Department of Pediatrics, Rush University Medical Center, Chicago, IL.

Donna Geddes (D)

School of Molecular Sciences, University of Western Australia, Perth, WA, Australia.

Paula P Meier (PP)

Division of Neonatology, Department of Pediatrics, Rush University Medical Center, Chicago, IL; College of Nursing, Rush University Medical Center, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH